Stay updated on GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial

Sign up to get notified when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site revision label has been updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T20:20:33.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-02-14T04:57:05.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-06T22:48:18.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Glossary visibility controls were added (Show glossary / Hide glossary) to the page. Versioning and label formatting were updated: the revision is now v3.4.0, capitalization of QC-related labels was standardized (No FEAR Act data; Last Update Submitted that Met QC Criteria), and the older v3.3.4 entry was removed.
    Difference
    0.2%
    Check dated 2026-01-23T17:29:20.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T11:54:20.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Locations section expanded with new enrollment sites across the United States and internationally, increasing potential participant access. New sites include multiple US states (AZ, AR, CA, FL, GA, IL, IA, KY, LA, MD, MN, MS, NE, NJ, NY, NC, OH, OK, PA, TN, TX, VA, WI) and international regions (Alberta, British Columbia, Nova Scotia, Ontario, Centre-Val de Loire, Haute-Garonne, Somme, Attica, Dublin, Tel Aviv, Campania, Emilia-Romagna, Lombardy, Milano, Lower Silesian Voivodeship, Lublin, Lisbon District, București, Samara Oblast, Taichung, Essex, London City).
    Difference
    2%
    Check dated 2025-12-18T21:59:29.000Z thumbnail image

Stay in the know with updates to GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.